Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.
about
Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisGuillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or VaccinationDouble Roles of Macrophages in Human Neuroimmune Diseases and Their Animal ModelsPeripheral neuropathy: clinical and electrophysiological considerations.Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome[Guillain-Barré syndrome after exposure to influenza].The Sequential Ultrasonographic, Electrophysiological and MRI Findings in a Patient with the Pharyngeal-cervical-brachial Variant of Guillain-Barré Syndrome from the Acute Phase to the Chronic Phase.New concepts of Guillain-Barré syndrome.Campylobacter species and Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: a critical review.Diagnosis of motor neuropathy.Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Clinical features and prognosis with Guillain-Barré syndrome.Campylobacter 0:41 isolation in Guillain-Barré syndrome.Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin.Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.Management of inflammatory neuropathiesPathogenesis of Guillain-Barre syndrome.Anti-ganglioside antibodies alter presynaptic release and calcium influxGuillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.Guillain-Barré syndrome and its treatment.Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes.An update in guillain-barré syndromeTreatment in inflammatory neuropathies.CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy.Recent developments and future directions in Guillain-Barré syndrome.Pathophysiology of immune-mediated demyelinating neuropathies-part I: neuroscience.Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study.Mechanisms of distal axonal degeneration in peripheral neuropathies.Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome.Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
P2860
Q22241939-8D7D9B53-8921-4968-9817-4B698ABABA88Q22251013-4EA9FB97-EC6D-4E31-94A5-842C561931D2Q24276196-85FF1A5A-B955-4C45-81A3-EF36D809226DQ26749131-58049664-7249-4FBE-B0FF-3E45C87A2D24Q27693190-35D26219-DEB4-4C25-B4CA-C24A4BC1EAC7Q28297319-A2A59DDE-B934-4FFB-A26C-7F433AEE1273Q30415924-2FB6AECB-A2FD-4B73-8616-C9D9C7AA93A9Q32182121-212A89DF-DEDA-4581-A14B-58B162744E4EQ33886911-7F24BD20-0867-49C1-BBA3-96748C5542C4Q33975353-759FFA44-8E4F-4E96-851A-619BB7F50CC6Q34235801-7D9B9AA9-A6CF-4FC9-B652-111049343A6DQ34235867-4F7D13E8-618D-47FC-AAE8-14419FF1BE0CQ34556837-B64B73CD-79ED-4568-9344-DD325292C540Q34619162-8677F267-2F69-4105-B7D8-39CC992888EDQ35121624-E3B8E162-BF21-4EE7-B76B-43CE2ED316BFQ35255750-9171D300-A52F-47CF-B53E-6D5F79C7B187Q35331829-F318B7D3-1B9A-4F70-B14F-0E64DC4F1BE2Q35455283-9D5C7AC6-1F49-4075-A1B3-EB81C0046E00Q35547885-7C2966EB-2CDE-4737-BFAB-D3AC57B47A37Q35576432-022B8B73-F451-4F8B-9864-F038C69FF42AQ35917297-E75D9CD3-59FF-4A07-AF85-D8521EDB0F78Q36168575-09E8C97E-75E9-4A4C-A297-809B4C2367F7Q36174702-BD0882F6-CEDB-4876-BD7E-4DE645BE8D19Q36641540-B582ED88-F365-4B22-951C-78FE0D2312B8Q36896911-7CFDDEFA-D2D7-43EC-B63D-F8C2B9E7A088Q37016196-E5BFD2F3-E50F-4E7C-8057-7DA1AF6C7667Q37507978-88E9FB75-422A-4649-9BCA-F83715425166Q37544140-5AEE7C01-4927-4F61-9CF8-42DEA740ED28Q37733512-B50B2F1D-7FEC-47F5-A95E-F84EC4E927AEQ37866845-93E76739-408B-4B83-807F-0DBF494724A7Q38070878-2C5D35B3-A571-4045-A9C1-DC19723C1327Q38070887-F06E482A-FE76-4B0F-98A3-9601B810B415Q38134344-22B910F4-509A-4A57-A68F-A45953DA45A8Q38300498-0F900321-72BD-4A52-81F0-EF828CB849D1Q38330759-0880552F-5DDC-49F7-B56D-A7C0A5392E82Q38333532-CC0B7917-16F6-4FA2-9CCA-EF62143AAC0DQ38474826-723694A5-E4C6-4DED-B219-4B271B554584Q38587703-DE105D38-24BB-4C1C-8659-A8F2A2CC439DQ38605062-637AC3FB-C3A6-4675-8344-F421A9DF15F8Q38868347-FEBE5721-E137-461F-9542-EE341C0D9F8F
P2860
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Guillain-Barré syndrome in nor ...... s in clinically defined cases.
@en
type
label
Guillain-Barré syndrome in nor ...... s in clinically defined cases.
@en
prefLabel
Guillain-Barré syndrome in nor ...... s in clinically defined cases.
@en
P2093
P921
P356
P1433
P1476
Guillain-Barré syndrome in nor ...... s in clinically defined cases.
@en
P2093
Cornblath DR
Griffin JW
P304
P356
10.1093/BRAIN/118.3.577
P407
P478
118 ( Pt 3)
P50
P577
1995-06-01T00:00:00Z